BSE filing, NSE: IXIGO. Summary written from the filing by ALFA Finder's alert engine.
LE Travenues Technology Ltd: key numbers
- Share price
- ₹140.00
- Market cap
- ₹6,178 Cr
- Revenue (annual)
- ₹1,228 Cr
- Net profit (annual)
- ₹72.13 Cr
- P/E (TTM)
- 41.2×Sector 34.0×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 56.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from LE Travenues Technology Ltd
All →LE Travenues Technology Earnings Call Transcript: Key Takeaways
Ixigo delivered record PAT of ₹63.4 Cr, inflated by a ₹40.66 Cr one-time gain from Freshbus stake sale.
LE Travenues Technology Results Update
ixigo reported Q2 FY27 revenue of Rs. 320.96 crore and a record profit after tax of Rs. 63.42 crore, driven by strong growth in its hotel business.
LE Travenues Technology Investor Presentation: Key Takeaways
Ixigo delivered strong Q2 FY27 results with 13% YoY revenue growth and 22% GTV growth. The company reported record PAT, driven by core growth and a partial stake sale in Freshbus.
LE Travenues Technology Management Change
Le Travenues Technology Limited has re-appointed PricewaterhouseCoopers Services LLP as the Internal Auditor of the Company for a term of 12 months.
- Execution
- 12 months
LE Travenues Technology Employee Stock Options
Le Travenues Technology allotted 173,780 equity shares upon the exercise of employee stock options. This issuance increases the company's paid-up share capital.
LE Travenues Technology Q2 FY27 Results: Turns Profitable, Net Profit ₹63.4 Cr
LE Travenues Technology Ltd reported revenue from operations of ₹321 Cr (+12.9% YoY) and net profit of ₹63.4 Cr for Q2 FY27.
- Key figure
- Net profit ₹63.4 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.